Avoiding Added Matter Pitfalls: Mastering Amendments Before the EPO

​
June 17, 2025

"Added matter" objections are a common and often frustrating hurdle in European patent prosecution. The European Patent Office (EPO) takes a particularly strict stance on claim amendments, especially when compared to more flexible jurisdictions like the United States Patent and Trademark Office (USPTO). To ensure procedural efficiency and help reduce prosecution costs, it is advised that non-European practitioners familiarise themselves with the EPO's approach to added matter.

This article explores the intricacies of added matter objections before the EPO and offers practical advice to help ensure a smoother prosecution process.

What Is Added Matter?

According to Article 123(2) EPC a patent application or granted patent may not be amended in such a way that it contains subject-matter which extends beyond the content of the application as filed. This means that, following an amendment, the skilled person must not be presented with any new technical information that was not already present in the application as filed.

The term "application as filed" refers to the originally filed description, drawings, and claims (but not the abstract). Subject matter from another application that is incorporated by reference is only relevant in very limited circumstances. The "incorporation by reference" doctrine is not generally recognised at the EPO.

The rationale behind this provision is to protect legal certainty. Applicants should not be allowed to improve their legal position by introducing subject matter not originally disclosed, as this could unfairly affect third parties who rely on the original content to assess potential infringement risks.

How Is It Assessed?

The EPO apply the "Gold Standard" test for assessing whether an amendment adds matter (as set out in decisions G 3/89 and G 2/10). The Gold Standard states that an amendment does not add matter beyond the contents of the application as filed if the skilled person, at the filing date, applying their common general knowledge, would directly and unambiguously derive the amendment from the application as filed. This effectively means that if the amended features are not disclosed verbatim in the specification, they must be clearly disclosed in some other manner.

Although added matter is assessed from the viewpoint of the skilled person using common general knowledge, this does not mean that a feature can be added to a claim if the skilled person knows the feature is common in the relevant field. In addition, if a feature is not implicitly or explicitly disclosed, the feature cannot be added to a claim if it is merely rendered obvious by the application's disclosure. In other words, the common general knowledge cannot serve to enlarge or replace, in a subjective or artificial manner, the actual content of the original specification.

Instead, an added feature must be at least implicitly disclosed in the original specification (an implicit disclosure is that which the skilled person would consider is a clear and unambiguous consequence of what is explicitly mentioned in the specification).

How to Avoid Added Matter Objections

General

When filing amended claims, a marked-up version showing the changes should be submitted. In the accompanying submission letter, each amendment must be clearly explained, with precise references to the original application (e.g., specific paragraphs or line numbers). Ideally, relevant excerpts from the description should be quoted directly. It is noted that these rules should be followed whenever amendments are being filed, such as when filing a response to an office action, when filing amended claims for an ex-PCT application, when filing divisional claims, and when filing voluntary claim amendments.

If the amendment is not disclosed verbatim, the submission letter must explain why the skilled person would still directly and unambiguously derive the feature from the original application. Failure to adequately substantiate how the amendments comply with Article 123(2) EPC will usually lead to an objection, and in some cases, the EPO may even decline to conduct a search or continue examination on substantive grounds until a set of claims complying with Article 123(2) EPC is filed.

Intermediate Generalisations

An "unallowable intermediate generalisation" is a particular type of added matter objection where a claim is amended to include a particular feature, but fails to include one or more additional features that are disclosed in combination with that particular feature. As an example, if a claim includes features A and B, and the description describes an embodiment containing features A, B, C and D, it must be assessed whether the claim can be amended to include feature C, but not feature D.

To be allowable, the EPO applies a two-step test (see EPO Guidelines Part H – Chapter V-14, 3.2.1):

  1. The added feature must not be inextricably linked to the omitted features (i.e., the omitted features must not be necessary for achieving the technical effect associated with the added feature); and
  2. The overall disclosure must support the isolation of the added feature and its introduction into the claim.

To avoid an objection based on intermediate generalisation, the submission letter to the EPO should therefore explain why the amendment satisfies this test. Returning to the earlier example, an option would be to point to a part of the description that explains or implies that feature D is optional.

Deletion of Features

An added matter objection can also arise when a feature is removed from an originally filed claim on the ground that a new disclosure of the remaining features in combination without the omitted feature constitutes a new teaching not found in the original specification. To be allowable, the EPO applies a three-step test (as set out in decision T 331/87):

  1. The removed feature must not be described as essential in the original disclosure;
  2. The skilled person must directly and unambiguously recognise that the feature is not indispensable for the function of the invention in the light of the technical problem the invention serves to solve; and
  3. The skilled person must recognise that the removal requires no modification of the other claim features to compensate for the change (it does not in itself alter the invention).

As with intermediate generalisations, the submission letter should clearly demonstrate how these criteria are met.

The "Inescapable Trap"

Under Article 123(3) EPC, a granted European patent cannot be amended in a way that the scope of protection is broadened. In conjunction with an added matter objection, this creates a potential "inescapable trap": if a granted claim is found to contain added matter, but removing the objectionable feature would broaden the claim beyond what was granted, then the patent would be invalid in a manner that could not be cured by amendment (unless there happens to be an alternative amendment that does not involve added matter and is narrower in scope than the amendment held to add matter).

To avoid falling into this trap, it is crucial to assess every amendment for compliance with Article 123(2) before grant. Post-grant, the consequences of added matter are much more severe and may even be fatal to the patent.

The danger of an inescapable trap means that great care must be taken with regard to added matter during prosecution, even if the issue is not raised by the examiner. Moreover, even an amendment suggested by an examiner can be held to involve added matter after grant, so it should not be assumed that an examiner's proposal actually complies with Article 123(2). Responsibility for the amendment always remains with the applicant, even when adopting a course suggested by the examiner.

Final Thoughts

When amending claims in Europe, practitioners must apply a far more rigorous approach than may be required in other jurisdictions, such as the US. Frequently it is found that amendments that are acceptable in the US are objected to in Europe.

In addition to the advice set out above, a patent application can be made more robust at the drafting stage. For example, the following points may be taken into account while drafting a patent application:

  • Optional Features: If a feature is (or could be) optional, say so explicitly or describe alternative embodiments without it. This aids future amendments and helps avoid intermediate generalisation objections;
  • Broad Terminology: Broadening away from specific language used in a specification can be difficult. Accordingly, when describing multiple specific embodiments, include broad language encompassing them. For example, if describing a temperature sensor, pressure sensor, and fluid flow sensor, also state that the device includes "one or more sensors" to preserve flexibility;
  • Finalised Claims: Submit claims that are as complete and final as possible at the outset. If there are several ways to phrase something, include all those options in the description. Avoid relying on prosecution to refine claim language, since post-filing amendments are subject to the EPO's strict added matter provisions.

By understanding and respecting the EPO's stringent approach to added matter, practitioners can better navigate prosecution, reduce costs, and ensure more robust European patents.

The Latest Thought Leadership pieces in the Content Hub

No items found.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
Quantum IP Strategy: Own control Points, Not Patent Counts
14 October 2026
In quantum, the strongest portfolios will not be the biggest. Stuart Malcolm sets out six moves for owning the control points the market cannot route around, and the questions investors will ask.
#
Consulting
​
Targeted, Not Transformative: The UKIPO’s Considered Course on SEPs
13 October 2026
Andrew Sharples analyses the UKIPO's response to its SEP consultation, exploring proposed changes to FRAND dispute resolution, SEP transparency and licensing guidance, and what they mean for SEP holders and implementers.
#
Consulting
​
Chinese Companies in European Patent Litigation
30 September 2026
Chinese companies are becoming increasingly active in European patent litigation, both as defendants and as patent owners enforcing their own rights. This article examines the growing role of Europe and the Unified Patent Court (UPC) in global patent disputes, highlighting key cases involving Chinese businesses and the strategic opportunities and risks that come with operating in European markets. It is the first in a series exploring the practical implications of European patent enforcement for Chinese companies.
#
Patenting
​
How to mitigate prior art traps for follow-on pharma patents
27 August 2026
Follow-on patents are increasingly important for pharmaceutical innovators. Learn how new EMA clinical trial disclosure rules create prior art risks and discover practical strategies to protect pharmaceutical IP and maximise patent value.
#
Consulting
​
Chinese companies and the UPC: from enforcement targets to strategic users
13 August 2026
Chinese companies are playing an increasingly significant role in UPC litigation, accounting for around 38% of infringement actions in 2025. While many remain defendants, a growing number are actively using the Unified Patent Court to enforce their own patent rights across Europe. The trend highlights the UPC's rising importance for Chinese businesses operating in sectors such as telecommunications, semiconductors, medical devices and renewable energy, and signals a shift in global patent enforcement strategy.
#
Patenting
​
Evaluating the environmental impact of patent AI.
31 July 2026
AI's environmental impact is rarely out of the headlines, but how does it compare to the benefits it delivers in practice? In this article, Laurence Brown examines the energy use of AI-assisted patent drafting, comparing it with traditional drafting workflows. While measuring AI's true environmental footprint is far from straightforward, the analysis suggests that AI-assisted patent drafting may already be more energy efficient, while delivering significant productivity gains for patent professionals.
#
Patenting
​
UPC appeals after three years: Early indications on appeal success rates
15 July 2026
Three years into the UPC, appeal overturn rates sit at 56% for both substantive and preliminary injunction cases, with Kodak v Fujifilm among the rulings reshaping outcomes on appeal.
#
Litigation
​
The UPC After Three Years: From Experiment to Enforcement Forum
15 July 2026
1,282 cases filed at the UPC in three years: infringement actions have surged while revocation filings stayed flat, easing fears the Court would become a European patent graveyard.
#
Litigation
​
Podcast: Building an AI-Native Law Firm
26 June 2026
On the Technically Legal podcast, EIP partner Laurence Brown discusses how Visser AI is redesigning patent workflows, letting the firm offer fixed fees without trading away speed or quality.
#
Patenting
​
Choosing your SEP battleground: UPC, Germany or UK?
07 June 2026
Choosing the right venue for SEP litigation can significantly influence the outcome of FRAND disputes. This article compares the UPC, German and UK courts, examining their approaches to injunctions, FRAND defences, rate-setting and enforcement. It highlights the strategic advantages of each jurisdiction and explains why many SEP owners are increasingly turning to the UK and UPC as part of their European enforcement strategy.
#
Litigation
​
Synthetic Lethality & AI: IP Strategy in Oncology
26 May 2026
This article explores the resurgence of synthetic lethality in precision oncology, highlighting how AI and machine learning are accelerating the discovery of new therapeutic targets. It also examines growing clinical activity, investment, and the evolving intellectual property challenges shaping this emerging field.
#
Consulting
​
Inside the Visser AI Launch Party
20 May 2026
EIP has officially launched Visser AI®, our hybrid intelligence service for patent drafting and prosecution. Watch the launch film from our event at The Boundary in Shoreditch, and discover how our team of European and US patent attorneys — working with the Patently AI platform , delivers faster, lower-cost work at the EPO, USPTO and beyond.
#
Consulting
​
Protecting Your Startup: Five Intellectual Property Mistakes to Avoid
20 May 2026
Early‑stage startups often focus on product development and fundraising, but overlooking intellectual property (IP) can seriously damage long‑term value. This article explores five common IP mistakes startups make, with a particular focus on patents. It covers the risks of filing patents without professional advice, making public disclosures too early, failing to put enforceable contracts in place with third parties, misunderstanding what patent rights actually provide, and neglecting to develop a clear IP strategy. By highlighting these pitfalls and offering practical guidance, the article helps startups protect their innovations, strengthen their commercial position, and improve their prospects with investors.
#
Consulting
​
Technology, Patents, and Sport
13 May 2026
VAR, goal-line tech, AI 3D player avatars, wearable trackers, the technology reshaping the 2026 World Cup and elite sport rests on a patent system that makes the R&D investment behind it worth taking.
#
Patenting
​
Patents or Trade Secrets? When to Patent in Deep Tech Innovation
11 May 2026
Deep tech companies face unique IP challenges due to long development cycles, high upfront investment, and complex technologies that combine products and processes. This article explores when patents, trade secrets, or a combination of both offer the strongest protection. It explains how factors such as detectability, reverse engineering risk, disclosure to third parties, and employee mobility should shape IP strategy decisions. While patents are often best suited to externally visible or licensable technologies, trade secrets can be highly effective for internal processes and know‑how that deliver performance or cost advantages.
#
Patenting
​